-
1 Comment
Healius Limited is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Healius Limited's total revenue sank by 0.0% to $473M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $33M since the same quarter in the previous year.
Finally, its free cash flow grew by 149.2% to $126M since the same quarter in the previous year.
Based on the above factors, Healius Limited gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | AU0000033359 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Market Cap | 567M |
---|---|
PE Ratio | None |
Target Price | None |
Beta | 0.63 |
Dividend Yield | None |
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PGZ.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025